Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Sivori

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|December 24, 2019
Harnessing NK Cells for Cancer TreatmentPaola Minetto, Fabio Guolo, Silvia Pesce, et al.
European Journal of Immunology|November 25, 2003
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicityEmanuela Marcenaro, Raffaella Augugliaro, Michela Falco, et al.
Plos Medicine|September 21, 2006
In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytesGiovanna Zanoni, Riccardo Navone, Claudio Lunardi, et al.
Frontiers in Immunology|October 31, 2018
New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR ExpressionSilvia Pesce, Margherita Squillario, Marco Greppi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Analysis of <i>KIR3DP1</i> Polymorphism Provides Relevant Information on Centromeric <i>KIR</i> Gene ContentMaria Bono, Daniela Pende, Alice Bertaina, et al.
Frontiers in Cell and Developmental Biology|March 13, 2020
miRNAs in NK Cell-Based Immune Responses and Cancer ImmunotherapySilvia Pesce, Marco Greppi, Elisa Ferretti, et al.
Cancers|December 16, 2020
Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors SurveillanceElisa Ferretti, Simona Carlomagno, Silvia Pesce, et al.
Blood|May 3, 2002
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemiaRégis T Costello, Simona Sivori, Emanuela Marcenaro, et al.
Molecular Aspects of Medicine|August 18, 2020
NK cells and ILCs in tumor immunotherapySimona Sivori, Daniela Pende, Linda Quatrini, et al.
Cytometry. Part B, Clinical Cytometry|January 6, 2017
Markers and function of human NK cells in normal and pathological conditionsGenny Del Zotto, Emanuela Marcenaro, Paola Vacca, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|December 24, 2019
Harnessing NK Cells for Cancer TreatmentPaola Minetto, Fabio Guolo, Silvia Pesce, et al.
European Journal of Immunology|November 25, 2003
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicityEmanuela Marcenaro, Raffaella Augugliaro, Michela Falco, et al.
Plos Medicine|September 21, 2006
In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytesGiovanna Zanoni, Riccardo Navone, Claudio Lunardi, et al.
Frontiers in Immunology|October 31, 2018
New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR ExpressionSilvia Pesce, Margherita Squillario, Marco Greppi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Analysis of <i>KIR3DP1</i> Polymorphism Provides Relevant Information on Centromeric <i>KIR</i> Gene ContentMaria Bono, Daniela Pende, Alice Bertaina, et al.
Frontiers in Cell and Developmental Biology|March 13, 2020
miRNAs in NK Cell-Based Immune Responses and Cancer ImmunotherapySilvia Pesce, Marco Greppi, Elisa Ferretti, et al.
Cancers|December 16, 2020
Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors SurveillanceElisa Ferretti, Simona Carlomagno, Silvia Pesce, et al.
Blood|May 3, 2002
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemiaRégis T Costello, Simona Sivori, Emanuela Marcenaro, et al.
Molecular Aspects of Medicine|August 18, 2020
NK cells and ILCs in tumor immunotherapySimona Sivori, Daniela Pende, Linda Quatrini, et al.
Cytometry. Part B, Clinical Cytometry|January 6, 2017
Markers and function of human NK cells in normal and pathological conditionsGenny Del Zotto, Emanuela Marcenaro, Paola Vacca, et al.
Pageof 7